test

Charles Mathys

@Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (llc)

Latest period2024 - Q3ReportedManaged Assets$1.296BTotal holdings444
Assets growth rate-19.33%Assets growth rate (2-Q avg)-2.21%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (llc)'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 444 positions.

Assets under management

The assets under management (AUM) of Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (llc) over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.296B in assets, with a quarterly growth rate of -19.33% and a 2-quarter average growth rate of -2.21%. The portfolio is managed by Charles Mathys, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IFRXInflarx Nv
Recent Activity
Increased 10.55%
0.1%
$1.221M
797,876 shares@ $1.53 avg price
INZYInozyme Ph
Recent Activity
Increased 10.24%
0.1%
$1.183M
226,232 shares@ $5.23 avg price
STROSutro Biop
Recent Activity
Increased 22.97%
0.1%
$1.17M
338,222 shares@ $3.46 avg price
ESTAEstablishm
Recent Activity
Increased 62.98%
0.09%
$1.156M↑ Call
46,358 shares@ $24.93 avg price
AVBAvalonbay
Recent Activity
Increased 40.25%
0.09%
$1.137M
5,049 shares@ $225.25 avg price
MRSNMersana Th
Recent Activity
Increased 4.73%
0.09%
$1.077M
570,029 shares@ $1.9 avg price
XFORX4 Pharmac
Recent Activity
Increased 13.88%
0.08%
$1.037M
1.549M shares@ $0.67 avg price
NVNOEnvveno Me
Recent Activity
Increased 28.27%
0.08%
$994,664
296,031 shares@ $3.36 avg price
KPTIKaryopharm
Recent Activity
Increased 8.51%
0.08%
$992,824
1.196M shares@ $0.83 avg price
AURAAura Biosc
Recent Activity
Increased 17.97%
0.08%
$952,461
106,898 shares@ $8.91 avg price